Abstract

Drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) are a target for new antimicrobial technologies. Far-UVC technology is an emerging disinfection method that directly kills microorganisms using light. In contrast with conventional UV sterilization, far-UVC light has antimicrobial capabilities without apparent harm to mammalian cells. This study examines the application of 224 nm far-UVC light delivered from a laser using an optical diffuser towards the goal of protecting against bacterial invasion around skin penetrating devices. Delivery of far-UVC using a laser and optical fibers enables exposure to unique geometries that would otherwise be shielded when using a lamp. Testing of the bactericidal potential of diffusing the far-UVC laser output over a large area was tested and yielded qualitative area killing results. The killing of MRSA using this method was also examined using an in vitro survival assay. Results followed a classic log-linear disinfection model with a rate constant of k = 0.51 cm2/mJ, which corresponds to an inactivation cross section of D90 = 4.5 mJ/cm2. This study establishes far-UVC delivered from a laser through an optical diffuser as a viable solution for disinfection of susceptible regions such as around catheters, drivelines, or other skin penetrating medical devices.

Highlights

  • Infections from drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) present major health care challenges with over 23,000 cases resulting in death in the United States each year [1]

  • This study examines the use of far-UVC light generated from a laser source to be delivered via fiber optics to an optical diffuser element for bactericidal applications

  • An unmodified picture of the bacteria plate is shown in the inset of the figure

Read more

Summary

Introduction

Infections from drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) present major health care challenges with over 23,000 cases resulting in death in the United States each year [1]. Fighting these infections is a strain on limited healthcare resources considering the average length of a hospital stay is estimated at more than 11 days longer for infected individuals than those without infection [2]. While significant resources have been applied to combat infection from drug-resistant bacteria, and incremental gains have been reported, effective resolutions remain elusive.

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.